Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer

Item

http://www.wikidata.org/entity/Q36402491

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Comparison of efficacy of diff ...... table, advanced gastric cancer

@ast

Comparison of efficacy of diff ...... table, advanced gastric cancer

@en

type

Item

label

Comparison of efficacy of diff ...... table, advanced gastric cancer

@ast

Comparison of efficacy of diff ...... table, advanced gastric cancer

@en

prefLabel

Comparison of efficacy of diff ...... table, advanced gastric cancer

@ast

Comparison of efficacy of diff ...... table, advanced gastric cancer

@en

P1476

Comparison of efficacy of diff ...... table, advanced gastric cancer

@en

P2093

Caihua Zhang

http://www.w3.org/2001/XMLSchema#string

Chaogang Fan

http://www.w3.org/2001/XMLSchema#string

Guoli Li

http://www.w3.org/2001/XMLSchema#string

Jian Xu

http://www.w3.org/2001/XMLSchema#string

Jianmin Cao

http://www.w3.org/2001/XMLSchema#string

Ning Li

http://www.w3.org/2001/XMLSchema#string

Shen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer

Cancer statistics, 2006

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive

Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

P2888

1477-7819-10-162

P304

162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7819-10-162

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230670118

http://www.w3.org/2001/XMLSchema#string

P6179

1005072599

http://www.w3.org/2001/XMLSchema#string

P698

22891660

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

3499231

http://www.w3.org/2001/XMLSchema#string